Whitepapers/App Notes/Posters

Scientific briefing: Dissolution development Parvulet technology with oral tablets

Posted: 7 July 2021 | | No comments yet

Parvulet™ Technology is a patented oral dosage form capable of being dispensed to patients in tablet or powders, and converted into a semi-solid with water.

The final dosage is easily administered, as a soft food like texture, ideal for paediatric and geriatric populations. The Parvulet technology can be combined with our taste-masking and controlled release technologies, providing greater flexibility in advancing patient centric solutions.












    To read this scientific briefing in full, please complete the form below:

     









    This specialist content is provided to you free-of-charge thanks to the kind support of Adare Pharma Solutions

    By clicking submit you confirm that you accept our terms and conditions and privacy policy.

    Send this to a friend